Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
23.10
-0.12 (-0.52%)
At close: Sep 16, 2026, 4:00 PM EDT
23.21
+0.11 (0.48%)
After-hours: Sep 16, 2026, 5:12 PM EDT
Beam Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 156.04 | 139.74 | 63.52 | 377.71 | 60.92 | 51.84 | |
Revenue Growth | 158.89% | 120.01% | -83.18% | 520.01% | 17.51% | 215916.67% |
Cost of Revenue | 408.66 | 409.62 | 367.56 | 437.38 | 311.59 | 232.13 |
Gross Profit | -252.63 | -269.88 | -304.04 | -59.67 | -250.67 | -180.29 |
Selling, General & Admin | 125.4 | 113.82 | 111.53 | 116.81 | 87.81 | 57.22 |
Operating Expenses | 125.4 | 113.82 | 111.53 | 116.81 | 87.81 | 57.22 |
Operating Income | -378.02 | -383.69 | -415.57 | -176.49 | -338.48 | -237.51 |
Interest Expense | - | - | - | - | - | -0.01 |
Interest & Investment Income | 38.9 | 43.73 | 49.09 | 46.68 | 15.3 | - |
Earnings From Equity Investments | 255.15 | 255.15 | - | - | -25.5 | - |
Other Non Operating Income (Expenses) | -5.5 | 0.7 | 2.27 | 7.5 | 23.9 | -1 |
EBT Excluding Unusual Items | -89.48 | -84.11 | -364.2 | -122.31 | -324.78 | -238.52 |
Gain (Loss) on Sale of Investments | 2.42 | 3.94 | -14.09 | -18.59 | 20.2 | 17.69 |
Other Unusual Items | 0.54 | 0.18 | 1.59 | 9.74 | 18.9 | 5.15 |
Pretax Income | -86.52 | -79.99 | -376.7 | -131.16 | -285.68 | -370.64 |
Income Tax Expense | - | - | 0.04 | 1.37 | 3.41 | - |
Earnings From Continuing Operations | -86.52 | -79.99 | -376.74 | -132.53 | -289.09 | -370.64 |
Net Income | -86.52 | -79.99 | -376.74 | -132.53 | -289.09 | -370.64 |
Net Income to Common | -86.52 | -79.99 | -376.74 | -132.53 | -289.09 | -370.64 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 103 | 99 | 82 | 77 | 70 | 64 |
Shares Outstanding (Diluted) | 103 | 99 | 82 | 77 | 70 | 64 |
Shares Change | 16.29% | 20.16% | 6.69% | 10.19% | 9.01% | 37.44% |
EPS (Basic) | -0.84 | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 |
EPS (Diluted) | -0.84 | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -372.77 | -360.05 | -356.19 | -182.93 | -26.42 | -113.08 |
Free Cash Flow Per Share | -3.61 | -3.64 | -4.33 | -2.37 | -0.38 | -1.76 |
Gross Margin | -161.91% | -193.12% | - | -15.80% | - | - |
Operating Margin | -242.27% | -274.57% | -654.25% | -46.73% | -555.61% | -458.13% |
Profit Margin | -55.45% | -57.24% | -593.13% | -35.09% | -474.54% | -714.91% |
Free Cash Flow Margin | -238.90% | -257.65% | -560.77% | -48.43% | -43.38% | -218.11% |
EBITDA | -355.78 | -361.4 | -393.64 | -156.47 | -324.33 | -230.06 |
EBITDA Margin | -228.01% | -258.62% | - | -41.43% | - | - |
D&A For EBITDA | 22.24 | 22.29 | 21.93 | 20.01 | 14.15 | 7.45 |
EBIT | -378.02 | -383.69 | -415.57 | -176.49 | -338.48 | -237.51 |
EBIT Margin | -242.27% | -274.57% | - | -46.73% | - | - |